Conference Call with Piramal Enterprises Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Piramal Enterprises (PEL) Management and Analysts on the Company's Demerger of its Financial and Pharma businesses. Listen to the full transcript.